Funds · compare two funds
Are these two funds really different?
Pick two funds to see how much of their Indian equity is the same: the companies both hold, and what each holds that the other does not.
Data periodFund holdingsEach fund’s latest monthly disclosureNSE prices23 Oct 2026Data status →
NIPPON INDIA PHARMA FUND vs Motilal Oswal BSE Healthcare ETF
Overlap adds up, for every company both funds hold, the smaller of its two shares of each fund’s disclosed Indian equity: identical portfolios overlap 100%, funds with nothing in common 0%. A figure describes how alike the portfolios are; it is not a judgement of either fund. Method →
See both funds combined in the Portfolio X-ray →
Top shared holdings
34 companies both funds hold · largest common part first
Only in A
2 companies · largest first
Only in B
103 companies · largest first
- Laurus Labs Limited4.84%
- Torrent Pharmaceuticals Limited3.56%
- Glenmark Pharmaceuticals Limited2.19%
- Zydus Lifesciences Limited1.82%
- Krishna Institute of Medical Sciences Limited1.24%
- Aster DM Quality Care Limited1.18%
- Neuland Laboratories Limited1.16%
- Wockhardt Limited1.10%
- Acutaas Chemicals Limited1.06%
- Shilpa Medicare Limited0.77%
- Granules India Limited0.76%
- Global Health Limited0.76%
- Onesource Specialty Pharma Limited0.75%
- Rubicon Research Limited0.67%
- Jubilant Pharmova Limited0.51%
And 88 more.
Sector mix side by side
Share of each fund’s disclosed equity
| Sector | A | B | Difference |
|---|---|---|---|
| Healthcare | 92.4% | 94.1% | -1.72 pp |
| Consumer Services | 2.6% | 0.0% | +2.60 pp |
| Not classified | 5.0% | 5.9% | -0.89 pp |
Built from each fund’s latest monthly disclosure of Indian listed shares, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not part of the comparison. Not a recommendation. Method →